144 related articles for article (PubMed ID: 8692283)
21. Involvement of presynaptic H3 receptors in the inhibitory effect of histamine on serotonin release in the rat brain cortex.
Fink K; Schlicker E; Neise A; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1990 Nov; 342(5):513-9. PubMed ID: 1965326
[TBL] [Abstract][Full Text] [Related]
22. N-methyl-D-aspartate (NMDA)-stimulated noradrenaline (NA) release in rat brain cortex is modulated by presynaptic H3-receptors.
Fink K; Schlicker E; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1994 Feb; 349(2):113-7. PubMed ID: 8170496
[TBL] [Abstract][Full Text] [Related]
23. The metabolites N-desmethylclozapine and N-desmethylolanzapine produce cross-tolerance to the discriminative stimulus of the atypical antipsychotic clozapine in C57BL/6 mice.
Wiebelhaus JM; Webster KA; Meltzer HY; Porter JH
Behav Pharmacol; 2011 Sep; 22(5-6):458-67. PubMed ID: 21712711
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism.
Duncan GE; Miyamoto S; Leipzig JN; Lieberman JA
J Pharmacol Exp Ther; 2000 Apr; 293(1):8-14. PubMed ID: 10734147
[TBL] [Abstract][Full Text] [Related]
25. Subchronic treatment with either clozapine, olanzapine or haloperidol produces a hyposensitive response of the rat cortical cells to N-methyl-D-aspartate.
Jardemark KE; Liang X; Arvanov V; Wang RY
Neuroscience; 2000; 100(1):1-9. PubMed ID: 10996453
[TBL] [Abstract][Full Text] [Related]
26. The atypical antipsychotics risperidone, clozapine and olanzapine differ regarding their sedative potency in rats.
Ahnaou A; Megens AA; Drinkenburg WH
Neuropsychobiology; 2003; 48(1):47-54. PubMed ID: 12886041
[TBL] [Abstract][Full Text] [Related]
27. H3-receptor antagonists: synthesis and structure-activity relationships of para- and meta-substituted 4(5)-phenyl-2-[[2-[4(5)-imidazolyl]ethyl]thio]imidazoles.
Mor M; Bordi F; Silva C; Rivara S; Crivori P; Plazzi PV; Ballabeni V; Caretta A; Barocelli E; Impicciatore M; Carrupt PA; Testa B
J Med Chem; 1997 Aug; 40(16):2571-8. PubMed ID: 9258364
[TBL] [Abstract][Full Text] [Related]
28. Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo.
Willins DL; Berry SA; Alsayegh L; Backstrom JR; Sanders-Bush E; Friedman L; Roth BL
Neuroscience; 1999; 91(2):599-606. PubMed ID: 10366017
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological effects of zotepine and other antipsychotics on the central 5-HT2 receptors.
Czyrak A; Jaros T; Moryl E; Maj J
Pharmacopsychiatry; 1993 Mar; 26(2):53-8. PubMed ID: 7690975
[TBL] [Abstract][Full Text] [Related]
30. Imidazole H3-antagonists: relationship between structure and ex vivo binding to rat brain H3-receptors.
Vacondio F; Mor M; Silva C; Zuliani V; Rivara M; Rivara S; Bordi F; Plazzi PV; Magnanini F; Bertoni S; Ballabeni V; Barocelli E; Carrupt PA; Testa B
Eur J Pharm Sci; 2004 Sep; 23(1):89-98. PubMed ID: 15324926
[TBL] [Abstract][Full Text] [Related]
31. The discriminative stimulus properties of the atypical antipsychotic olanzapine in rats.
Porter JH; McCallum SE; Varvel SA; Vann RE
Psychopharmacology (Berl); 2000 Feb; 148(3):224-33. PubMed ID: 10755735
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of antipsychotic agents at human 5-HT(1A) receptors determined by [3H]WAY100,635 binding affinity ratios: relationship to efficacy for G-protein activation.
Newman-Tancredi A; Verrièle L; Touzard M; Millan MJ
Eur J Pharmacol; 2001 Oct; 428(2):177-84. PubMed ID: 11675034
[TBL] [Abstract][Full Text] [Related]
33. Mutual interactions of the presynaptic histamine H3 and prostaglandin EP3 receptors on the noradrenergic terminals in the mouse brain.
Schlicker E; Marr I
Neuroscience; 1997 Jul; 79(1):247-54. PubMed ID: 9178880
[TBL] [Abstract][Full Text] [Related]
34. Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum.
Ichikawa J; Dai J; O'Laughlin IA; Fowler WL; Meltzer HY
Neuropsychopharmacology; 2002 Mar; 26(3):325-39. PubMed ID: 11850147
[TBL] [Abstract][Full Text] [Related]
35. The atypical neuroleptics clozapine and olanzapine differ regarding their antinociceptive mechanisms and potency.
Schreiber S; Getslev V; Backer MM; Weizman R; Pick CG
Pharmacol Biochem Behav; 1999 Sep; 64(1):75-80. PubMed ID: 10495000
[TBL] [Abstract][Full Text] [Related]
36. Effects of typical and atypical antipsychotics on human glycine transporters.
Williams JB; Mallorga PJ; Conn PJ; Pettibone DJ; Sur C
Schizophr Res; 2004 Nov; 71(1):103-12. PubMed ID: 15374578
[TBL] [Abstract][Full Text] [Related]
37. Clozapine- and olanzapine-induced Fos expression in the rat medial prefrontal cortex is mediated by beta-adrenoceptors.
Ohashi K; Hamamura T; Lee Y; Fujiwara Y; Suzuki H; Kuroda S
Neuropsychopharmacology; 2000 Aug; 23(2):162-9. PubMed ID: 10882842
[TBL] [Abstract][Full Text] [Related]
38. Antipsychotic drugs induce similar effects on the release of dopamine and noradrenaline in the medial prefrontal cortex of the rat brain.
Westerink BH; de Boer P; de Vries JB; Kruse CG; Long SK
Eur J Pharmacol; 1998 Nov; 361(1):27-33. PubMed ID: 9851538
[TBL] [Abstract][Full Text] [Related]
39. Effect of zotepine, olanzapine and risperidone on hostility in schizophrenic patients.
Briken P; Nika E; Moritz S; Haasen C; Perro C; Yagdiran O; Naber D; Krausz M
Schizophr Res; 2002 Oct; 57(2-3):311-3. PubMed ID: 12223264
[No Abstract] [Full Text] [Related]
40. Increase of dialysate dopamine in the bed nucleus of stria terminalis by clozapine and related neuroleptics.
Carboni E; Rolando MT; Silvagni A; Di Chiara G
Neuropsychopharmacology; 2000 Feb; 22(2):140-7. PubMed ID: 10649827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
